BioQuarter development

As a keystone investment at the heart of Scotland’s national life science strategy, BioQuarter brings together public healthcare, academic research and extensive commercial laboratory space in one location to accelerate translational medicine and facilitate large-scale life science collaborations. The research base on site is globally recognised for:

• Cardiovascular research
• Reproductive biology
• Regenerative medicine
• Inflammation research
• Genomic technologies and informatics
• Reproductive sciences

Edinburgh BioQuarter includes

• The Royal Infirmary of Edinburgh
  A new 900-bed state-of-the-art teaching hospital.
• The University of Edinburgh Queen’s Medical Research Institute (QMRI)
  With adjoining Medical School research and teaching facilities. The QMRI provides facilities for interdisciplinary research in reproductive biology, cardiovascular science and inflammation research.
  Find out more on the QMRI website
• The Scottish Centre for Regenerative Medicine (SCRM). Announced in January 2007, the SCRM will be the next flagship science institution at BioQuarter. Find out more about the SCRM.
• The Institute for Stem Cell Research (ISCR).
  The ISCR is a world-leading centre for multidisciplinary research in mammalian stem-cell biology.
  Find out more on the ISCR website

World class research neighbours

• The Roslin Institute
  One of the world's leading centres for studies relating to animal genetics and development.
  Find out more on the Roslin Institute website
• The Moredun Research Institute
  Internationally recognised for its work on infectious diseases of sheep and other ruminants.
  Find out more on the Moredun Research Institute website

The Edinburgh BioQuarter offers

• An ideal location for translational medicine, and is the only site in the UK that offers co-location with a world-class teaching hospital, research university and commercial facilities. Edinburgh BioQuarter is home to acclaimed interdisciplinary research which provides a firm base on which to build new world-class biomedical ventures. On-site at BioQuarter, there are currently over 70 companies engaged in collaborations with Edinburgh scientists, including 17 of the world’s top 20 global pharmaceutical companies
• Access to research and opportunities for inter-disciplinary partnerships
• Access to pre-clinical bio-safety testing facilities, clinical trials protocol and management infrastructure
• Access to all of Scotland’s multi-centre clinical trials capabilities
• Flexible multi-user space: incubator, multi-occupancy and single-user investment
• Conference/meeting facilities and access to business development support
• An excellent built environment with superb infrastructure and facilities

 Download the Edinburgh BioQuarter brochure (PDF, 3.5Mb)

For more information, please contact us.